These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

550 related articles for article (PubMed ID: 33421515)

  • 1. Selecting End Points for Disease-Modification Trials in Inflammatory Bowel Disease: the SPIRIT Consensus From the IOIBD.
    Le Berre C; Peyrin-Biroulet L;
    Gastroenterology; 2021 Apr; 160(5):1452-1460.e21. PubMed ID: 33421515
    [TBL] [Abstract][Full Text] [Related]  

  • 2. STRIDE-II: An Update on the Selecting Therapeutic Targets in Inflammatory Bowel Disease (STRIDE) Initiative of the International Organization for the Study of IBD (IOIBD): Determining Therapeutic Goals for Treat-to-Target strategies in IBD.
    Turner D; Ricciuto A; Lewis A; D'Amico F; Dhaliwal J; Griffiths AM; Bettenworth D; Sandborn WJ; Sands BE; Reinisch W; Schölmerich J; Bemelman W; Danese S; Mary JY; Rubin D; Colombel JF; Peyrin-Biroulet L; Dotan I; Abreu MT; Dignass A;
    Gastroenterology; 2021 Apr; 160(5):1570-1583. PubMed ID: 33359090
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Proportion of inflammatory bowel diseases patients with suboptimal disease control in daily clinical practice-Real-world evidence from the inflammatory bowel diseases-podcast study.
    D'Amico F; Gomollón F; Bamias G; Magro F; Targownik L; Leitner C; Heatta-Speicher T; Michelena N; Kolterer S; Lapthorn J; Kauffman L; Dignass A;
    United European Gastroenterol J; 2024 Jul; 12(6):705-716. PubMed ID: 38733307
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Ulcerative Colitis and Crohn's Disease Have Similar Burden and Goals for Treatment.
    Le Berre C; Ananthakrishnan AN; Danese S; Singh S; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2020 Jan; 18(1):14-23. PubMed ID: 31301452
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Can we change the natural course of inflammatory bowel disease?
    Le Berre C; Danese S; Peyrin-Biroulet L
    Therap Adv Gastroenterol; 2023; 16():17562848231163118. PubMed ID: 37153497
    [TBL] [Abstract][Full Text] [Related]  

  • 6. CORE-IBD: A Multidisciplinary International Consensus Initiative to Develop a Core Outcome Set for Randomized Controlled Trials in Inflammatory Bowel Disease.
    ; Ma C; Hanzel J; Panaccione R; Sandborn WJ; D'Haens GR; Ahuja V; Atreya R; Bernstein CN; Bossuyt P; Bressler B; Bryant RV; Cohen B; Colombel JF; Danese S; Dignass A; Dubinsky MC; Fleshner PR; Gearry RB; Hanauer SB; Hart A; Kotze PG; Kucharzik T; Lakatos PL; Leong RW; Magro F; Panés J; Peyrin-Biroulet L; Ran Z; Regueiro M; Singh S; Spinelli A; Steinhart AH; Travis SP; van der Woude CJ; Yacyshyn B; Yamamoto T; Allez M; Bemelman WA; Lightner AL; Louis E; Rubin DT; Scherl EJ; Siegel CA; Silverberg MS; Vermeire S; Parker CE; McFarlane SC; Guizzetti L; Smith MI; Vande Casteele N; Feagan BG; Jairath V
    Gastroenterology; 2022 Oct; 163(4):950-964. PubMed ID: 35788348
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Time trends in therapies and outcomes for adult inflammatory bowel disease, Northern California, 1998-2005.
    Herrinton LJ; Liu L; Fireman B; Lewis JD; Allison JE; Flowers N; Hutfless S; Velayos FS; Abramson O; Altschuler A; Perry GS
    Gastroenterology; 2009 Aug; 137(2):502-11. PubMed ID: 19445944
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Defining endoscopic response and remission in ulcerative colitis clinical trials: an international consensus.
    Vuitton L; Peyrin-Biroulet L; Colombel JF; Pariente B; Pineton de Chambrun G; Walsh AJ; Panes J; Travis SP; Mary JY; Marteau P
    Aliment Pharmacol Ther; 2017 Mar; 45(6):801-813. PubMed ID: 28112419
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Clinical presentation of Crohn's, ulcerative colitis, and indeterminate colitis: Symptoms, extraintestinal manifestations, and disease phenotypes.
    Yu YR; Rodriguez JR
    Semin Pediatr Surg; 2017 Dec; 26(6):349-355. PubMed ID: 29126502
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SURGICAL MANAGEMENT OF ADULT CROHN'S DISEASE AND ULCERATIVE COLITIS PATIENTS: A CONSENSUS FROM THE BRAZILIAN ORGANIZATION OF CROHN'S DISEASE AND COLITIS (GEDIIB).
    Zabot GP; Cassol OS; Quaresma AB; Gonçalves Filho FA; Baima JP; Imbrizi M; Rolim AS; Carmo AMD; Alves Junior AJT; Santos CHMD; Sobrado Junior CW; Miranda EF; Albuquerque IC; Souza MM; Kaiser Junior RL; Parra RS; Kotze PG; Saad-Hossne R
    Arq Gastroenterol; 2023; 59(suppl 1):1-19. PubMed ID: 36995887
    [TBL] [Abstract][Full Text] [Related]  

  • 11. BRAZILIAN CONSENSUS ON THE MANAGEMENT OF INFLAMMATORY BOWEL DISEASES IN PEDIATRIC PATIENTS: A CONSENSUS OF THE BRAZILIAN ORGANIZATION FOR CROHN'S DISEASE AND COLITIS (GEDIIB).
    Lomazi EA; Oba J; Rodrigues M; Marmo MCDR; Sandy NS; Sdepanian VL; Imbrizi M; Baima JP; Magro DO; Albuquerque IC; Zabot GP; Cassol OS; Saad-Hossne R
    Arq Gastroenterol; 2023; 59(suppl 1):85-124. PubMed ID: 36995890
    [TBL] [Abstract][Full Text] [Related]  

  • 12. IOIBD technical review on endoscopic indices for Crohn's disease clinical trials.
    Vuitton L; Marteau P; Sandborn WJ; Levesque BG; Feagan B; Vermeire S; Danese S; D'Haens G; Lowenberg M; Khanna R; Fiorino G; Travis S; Mary JY; Peyrin-Biroulet L
    Gut; 2016 Sep; 65(9):1447-55. PubMed ID: 26353983
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Role of small-bowel endoscopy in the management of patients with inflammatory bowel disease: an international OMED-ECCO consensus.
    Bourreille A; Ignjatovic A; Aabakken L; Loftus EV; Eliakim R; Pennazio M; Bouhnik Y; Seidman E; Keuchel M; Albert JG; Ardizzone S; Bar-Meir S; Bisschops R; Despott EJ; Fortun PF; Heuschkel R; Kammermeier J; Leighton JA; Mantzaris GJ; Moussata D; Lo S; Paulsen V; Panés J; Radford-Smith G; Reinisch W; Rondonotti E; Sanders DS; Swoger JM; Yamamoto H; Travis S; Colombel JF; Van Gossum A;
    Endoscopy; 2009 Jul; 41(7):618-37. PubMed ID: 19588292
    [TBL] [Abstract][Full Text] [Related]  

  • 14. IOIBD Recommendations for Clinical Trials in Ulcerative Proctitis: The PROCTRIAL Consensus.
    Caron B; Abreu MT; Siegel CA; Panaccione R; Sands BE; Dignass A; Turner D; Dotan I; Hart AL; Ahuja V; Allez M; Ananthakrishnan AN; Ghosh S; Griffiths AM; Halfvarson J; Kaser A; Kotze PG; Koutroubakis IE; Lakatos PL; Levine A; Lewis JD; Magro F; Mantzaris GJ; O'Morain C; Ran Z; Reinisch W; Rogler G; Sachar DB; Siegmund B; Silverberg MS; Sood A; Spinelli A; Steinwurz F; Tysk C; Yamamoto-Furusho JK; Schreiber S; Rubin DT; Sandborn WJ; Danese S; Peyrin-Biroulet L
    Clin Gastroenterol Hepatol; 2022 Nov; 20(11):2619-2627.e1. PubMed ID: 35189386
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Differentiating ulcerative colitis from Crohn disease in children and young adults: report of a working group of the North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition and the Crohn's and Colitis Foundation of America.
    ; ; Bousvaros A; Antonioli DA; Colletti RB; Dubinsky MC; Glickman JN; Gold BD; Griffiths AM; Jevon GP; Higuchi LM; Hyams JS; Kirschner BS; Kugathasan S; Baldassano RN; Russo PA
    J Pediatr Gastroenterol Nutr; 2007 May; 44(5):653-74. PubMed ID: 17460505
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Diagnosis and treatment of inflammatory bowel disease: First Latin American Consensus of the Pan American Crohn's and Colitis Organisation.
    Yamamoto-Furusho JK; Bosques-Padilla F; de-Paula J; Galiano MT; Ibañez P; Juliao F; Kotze PG; Rocha JL; Steinwurz F; Veitia G; Zaltman C
    Rev Gastroenterol Mex; 2017; 82(1):46-84. PubMed ID: 27979414
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Evidence-based clinical practice guidelines for inflammatory bowel disease.
    Matsuoka K; Kobayashi T; Ueno F; Matsui T; Hirai F; Inoue N; Kato J; Kobayashi K; Kobayashi K; Koganei K; Kunisaki R; Motoya S; Nagahori M; Nakase H; Omata F; Saruta M; Watanabe T; Tanaka T; Kanai T; Noguchi Y; Takahashi KI; Watanabe K; Hibi T; Suzuki Y; Watanabe M; Sugano K; Shimosegawa T
    J Gastroenterol; 2018 Mar; 53(3):305-353. PubMed ID: 29429045
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Quality of life, work productivity impairment and healthcare resources in inflammatory bowel diseases in Brazil.
    Parra RS; Chebli JMF; Amarante HMBS; Flores C; Parente JML; Ramos O; Fernandes M; Rocha JJR; Feitosa MR; Feres O; Scotton AS; Nones RB; Lima MM; Zaltman C; Goncalves CD; Guimaraes IM; Santana GO; Sassaki LY; Hossne RS; Bafutto M; Junior RLK; Faria MAG; Miszputen SJ; Gomes TNF; Catapani WR; Faria AA; Souza SCS; Caratin RF; Senra JT; Ferrari MLA
    World J Gastroenterol; 2019 Oct; 25(38):5862-5882. PubMed ID: 31636478
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Converging goals of treatment of inflammatory bowel disease from clinical trials and practice.
    Levesque BG; Sandborn WJ; Ruel J; Feagan BG; Sands BE; Colombel JF
    Gastroenterology; 2015 Jan; 148(1):37-51.e1. PubMed ID: 25127678
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Development and content validation of patient-reported outcomes tools for ulcerative colitis and Crohn's disease in adults with moderate-to-severe disease.
    Nag A; Romero B
    Health Qual Life Outcomes; 2022 May; 20(1):75. PubMed ID: 35525935
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.